492PA multicenter phase II trial to evaluate the efficacy of mFOLFOX6+cetuximab as induction chemotherapy to achieve R0 surgical resection for advanced colorectal liver metastases (NEXTO trial). (23rd October 2018) - Nishioka, Y; Hasegawa, K; Saiura, A; Oba, M; Yamamoto, J; Nomura, Y; Takayama, T; Hashiguchi, Y; Shibasaki, M; Sakamoto, H; Yamagata, S; Aoyanagi, N; et al.